Pfizer Agrees to $486M Settlement with Shareholders Over Concealing Drug Risks

Pfizer Inc. on Tuesday said it has reached a $486 million settlement of litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. The accord is subject to negotiation …

from News – Insurance Journal